Prevention of HPV re-infection by HPV vaccination after conization in patients with CIN 3
Not Applicable
Recruiting
- Conditions
- Cervical intraepithelial neoplasia 3
- Registration Number
- JPRN-UMIN000003845
- Lead Sponsor
- Kansai Clinical Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
1)Adenocarcinomas 2)Previous HPV vaccination 3)Age of 40 years or over 4)Invasive cancer suggested with cytology, histology, and/or colposcopy before conization. 5)Patients who are found to have invasive cancer or who undergo hysterectomy from their own will after conization should be excluded from the study even after enrollment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Investigation on Post-conization HPV infection rate. 2. Investigation on post-conization HPV re-infection prophylazis.
- Secondary Outcome Measures
Name Time Method 1. Rate of recurrence of CIN 2. Significant adverse reactions to HPV vaccination